BG34-200 plus immunotherapy for canine malignant melanoma
The purpose of this study is to evaluate the effectiveness of a new cancer immune therapy, BG34-200, for the treatment of canine malignant mel
The purpose of this study is to evaluate the effectiveness of a new cancer immune therapy, BG34-200, for the treatment of canine malignant mel
The purpose of this study is to better understand the biology of primary bone cancer of the leg (appendicular osteosarcoma, OS) in dogs.
We are studying whether a low-dose radiation treatment to the whole abdomen can safely and effectively help cats with chronic inflammatory enteropa
In dogs with chronic kidney disease (CKD), the available medical management consists of supportive and symptomatic treatment with the goal of corre
Soft tissue sarcoma (STS) represents a type of cancer that has been difficult to treat with immune-based therapies across multiple species, includi
The purpose of this study is to evaluate the effectiveness of a new therapy for two different skin diseases in dogs: atopic dermatitis and cutaneou
The purpose of this study is to evaluate the combination of a new tumor vaccine given in combination with an oral therapy designed to stimulate the
Hemangiosarcoma (HSA) is a cancer of the cells lining the blood vessels that is very aggressive; it accounts for 5-7% of all cancers in dogs result
Heart disease is a very common problem in cats, with the most common form of feline heart disease being hypertrophic cardiomyopathy.
Rapamycin, a medication that affects both the immune system and metabolism, has been shown to increase the lifespan of mice.